Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00109473 · ClinicalTrials.gov registry record · Phase 2
Trial of Growth Hormone Therapy in Pediatric Crohn's Disease
A Phase 2 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT00109473 is a Phase 2 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 22 participants.
The verdict
NCT00109473, a Phase 2 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether taking a growth hormone (GH) drug called somatropin causes the intestine of a person with Crohn's Disease (CD) to heal faster when compared to a person with Crohn's Disease that does not receive growth hormone drug.
Interventions
- DRUG growth hormone
- DRUG cortecosteroid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2005-04 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00109473
The ClinicalTrials.gov registry entry for NCT00109473 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which growth hormone is the first listed.
NCT00109473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00109473 about?
NCT00109473 is a clinical study titled "Trial of Growth Hormone Therapy in Pediatric Crohn's Disease". The purpose of this study is to determine whether taking a growth hormone (GH) drug called somatropin causes the intestine of a person with Crohn's Disease (CD) to heal faster when compared to a person with Crohn's Disease that does not receive growth hormone drug.
What is the current status of trial NCT00109473?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2005-04. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00109473?
The interventions under investigation include: growth hormone (DRUG), cortecosteroid (DRUG).
Who is sponsoring clinical trial NCT00109473?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.